Adoption of direct-acting antiviral medications for hepatitis C: a retrospective observational study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1472-6963
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Adoption of direct-acting antiviral medications for hepatitis C: a retrospective observational study ; volume:19 ; number:1 ; day:25 ; month:7 ; year:2019 ; pages:1-7 ; date:12.2019
BMC health services research ; 19, Heft 1 (25.7.2019), 1-7, 12.2019
- Urheber
-
Zullig, Leah L.
Bhatia, Haresh L.
Gellad, Ziad F.
Eatherly, Mark
Henderson, Rochelle
Bosworth, Hayden B.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12913-019-4349-x
- URN
-
urn:nbn:de:101:1-2019121803343222195271
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:44 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Zullig, Leah L.
- Bhatia, Haresh L.
- Gellad, Ziad F.
- Eatherly, Mark
- Henderson, Rochelle
- Bosworth, Hayden B.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Medications that interact with direct-acting oral anticoagulant exposure
Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications
Direct-Acting Antiviral Therapy for Hepatitis C: Attitudes Regarding Future Use
Hepatic steatosis in HCV-infected persons in the direct-acting antiviral era
Direct-acting antiviral resistance of Hepatitis C virus is promoted by epistasis
HCV and kidney transplant in the era of new direct-acting antiviral agents (DAAs)
Acute reversible rhabdomyolysis during direct-acting antiviral hepatitis C virus treatment: a case report
Modeling HIV-HCV coinfection epidemiology in the direct-acting antiviral era: the road to elimination
Direct-acting antiviral treatment downregulates immune checkpoint inhibitor expression in patients with chronic hepatitis C
Perceived physical health outcomes of direct-acting antiviral treatment for hepatitis C: a qualitative study
Hepatitis C in healthcare personnel: secondary data analysis of therapies with direct-acting antiviral agents
Hepatitis C in healthcare personnel: follow-up analysis of treatments with direct-acting antiviral agents
Medications that interact with direct-acting oral anticoagulant exposure
Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications
Direct-Acting Antiviral Therapy for Hepatitis C: Attitudes Regarding Future Use
Hepatic steatosis in HCV-infected persons in the direct-acting antiviral era
Direct-acting antiviral resistance of Hepatitis C virus is promoted by epistasis
HCV and kidney transplant in the era of new direct-acting antiviral agents (DAAs)
Acute reversible rhabdomyolysis during direct-acting antiviral hepatitis C virus treatment: a case report
Modeling HIV-HCV coinfection epidemiology in the direct-acting antiviral era: the road to elimination
Direct-acting antiviral treatment downregulates immune checkpoint inhibitor expression in patients with chronic hepatitis C
Perceived physical health outcomes of direct-acting antiviral treatment for hepatitis C: a qualitative study
Hepatitis C in healthcare personnel: secondary data analysis of therapies with direct-acting antiviral agents
Hepatitis C in healthcare personnel: follow-up analysis of treatments with direct-acting antiviral agents
Medications that interact with direct-acting oral anticoagulant exposure
Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications
Direct-Acting Antiviral Therapy for Hepatitis C: Attitudes Regarding Future Use
Hepatic steatosis in HCV-infected persons in the direct-acting antiviral era
Direct-acting antiviral resistance of Hepatitis C virus is promoted by epistasis
HCV and kidney transplant in the era of new direct-acting antiviral agents (DAAs)
Acute reversible rhabdomyolysis during direct-acting antiviral hepatitis C virus treatment: a case report
Modeling HIV-HCV coinfection epidemiology in the direct-acting antiviral era: the road to elimination
Direct-acting antiviral treatment downregulates immune checkpoint inhibitor expression in patients with chronic hepatitis C
Perceived physical health outcomes of direct-acting antiviral treatment for hepatitis C: a qualitative study
Hepatitis C in healthcare personnel: secondary data analysis of therapies with direct-acting antiviral agents